COVE-1: A Phase 2, Open-Label Study to Evaluate Efficacy and Safety and the Optimal Regimen of VP-102, a Proprietary Drug–Device Product Containing Topical Cantharidin (0.7% w/v) Under Occlusion for the Treatment of Common Warts

INTRODUCTION: Verrucae vulgaris, or common warts, is a common skin condition for which there is no US Food and Drug Administration-approved treatment. Compounded cantharidin has been used to treat warts for years but lacks a controlled formulation, consistent application schedule and methods, and ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Guenthner, Scott, McFalda, Wendy, Kwong, Pearl, Eads, Kimberly, McCafferty, Morgan, Rieger, Jayson, Glover, David K., Willson, Cynthia, Burnett, Patrick, Olivadoti, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484407/
https://www.ncbi.nlm.nih.gov/pubmed/34286459
http://dx.doi.org/10.1007/s13555-021-00576-y

Ejemplares similares

Ejemplares similares